Analysis of T cell receptor V(β) gene usage during the course of disease in patients with chronic hepatitis B

Journal of Biomedical Science

Volumn 5, Issue 6, 1998, Pages 428-434

  Dou, Horng Yunn ^b   Wu, Jaw Ching ^a   Peng, Wei Li ^a   Chang, Chungming ^b,c   Chi, Wei Kuang ^d   Chu, Yi Ding ^d   Hu, Cheng Po ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d DEVELOPMENT CENTER FOR BIOTECHNOLOGY   (Taiwan)

Author keywords

Chronic HBV infection; Immune response; T cell receptor; V( ) gene usage

Indexed keywords

HEPATITIS B CORE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; ARTICLE; CHRONIC HEPATITIS; DISEASE COURSE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; RECEPTOR GENE; REMISSION; T LYMPHOCYTE SUBPOPULATION; VIRUS REACTIVATION;

HEPATITIS B VIRUS;

EID: 0031774238     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02255931     Document Type: Article

References (22)

1. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,701 men in Taiwan. Lancet ii:1129-1133;1981.
2. Chisari FV, Ferrari C. Hepatitis B virus irnmunopathogenesis. Annu Rev Immunol 13;29-60:1995.
3. Chisari FV, Ferrari C, Mondelli MU. Hepatitis B virus structure and biology. Microb Pathog 6: 311-325;1989.
4. Davis GL, Hoofnagle JH. Reactivation of chronic hepatitis B virus infection. Gastroenterologv 92:2028-2031;1987.
5. Ferradini L, Mackensen A, Genevee C, Bosq J, Duvillard P, Avril MF, Hercend T. Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion. JOin Invest 91:1183-1190;1993.
6. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25-36;1996.
7. Hsieh, JH, Shih KY, Kung HF, Shiang M, Lee LY, Meng MH, Chang CC, Lm HM, Shih SC, Lee SY, Chow, TV, Feng TY, Kuo TT, Choo KB Controlled fed-batch fermentation of recombinant Saccharomyces cerevisiae to produce hepatitis B surface antigen. Biotech Bioeng 32:334-340;1988.
8. Kalams SA, Johnson RP, Trocha AFC, Dynan MJ, Ngo HS, D'Aquila RT, Kurnick JT, Walker BD. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J ExpMed 179:1261-1271;1994.
9. Kotzin BL, Karuturi S, Chou YK, Lafferty J, Forrester JM, Better M, Nedwin GE, Offner H, Vandenbark AA. Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. Proc Natl Acad Sci USA 88:9161-9165;1991.
10. Liaw YF, Yang SS, Chen TJ, Chu CM. Acute exacerbation in hepatitis B e antigen positive chronic type B hepatitis: A clinicopathological study. J Hepatol. 1:227-233;1985.
11. Liaw YF, Pao CC, Chu CM. Changes of serum HBV DNA in relation to serum transaminase level during acute exacerbation in patients with chronic type B hepatitis. Liver 8:231-235; 1988.
12. Lohr HF, Gerken G, Schlicht HJ, Meyer zum Buschenfelde KH, Fleischer B. Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B. J Infect Dis 168:1133-1139;1993.
13. Mels GC, Bellati G, Leandro G, Brunetto MR, Vicari O, Borzio M, Piantmo P, Fomaciari G, Scudeller G, Angeli G, Bonino F, Ideo G. Fluctuations in viremia. aminotransferases and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbation. Liver 14:175-181;1994.
14. Moss PAH, Rosenberg WMC Bell JI. The human T cell receptor in health and disease. Annu Rev Immunol 10:71-96;1992.
15. Puisieux I, Even J, Pannetier C, Jotereau F, Favrot M, Kourilsky P. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J Immunol 153:2807-2818;1994.
16. Rehermann B, Pasquinelli C, Mosier SM, Chisari FV. Hepatitis B virus (HBV) sequence variation in cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection. J Clin Invest 96:1527-1534;1995.
17. Shannmugam A, Copie-Bergman C, Falissard B, Delrieu O, Jais JP, Rebibo D, Bach JF, Toumier-Lasserve E. TCR ab gene usage for myelin basic protein recognition in healthy monozygous twins. J Immunol 156:3747-3754;1996.
18. Shu PY, Chang C, Hang LH, Hu C. Proliferative and cytotoxic T-cell clones recognize endogenously synthesized HBcAg in an asymptomatic HBsAg carrier. Hepatology 18:275-283;1993.
19. Shu PY, Lm MY, Chang C, Hwang JH, Huang JH. Chang TH, Hu C. Presence of hepatitis B surface antigen (HBsAg)-specific cytotoxic T cells in asymptomatic HBsAg carriers. J Infect Dis 169:633-637;1994.
20. Tsai SL, Chen PJ, Lai MY, Yang PM, Sung JL, Huang JH, Hwang LH, Chang TH, Chen DS. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. J Clin Invest 89:87-96;1992.
21. Uyemura K, Pirmez C, Sieling PA, Kiene K, Paes-Oliveira M, Modhn RL. CD4+ type 1 and CDS+ type 2 T cell subsets in human leishmaniasis have distinct T cell receptor repertoires. J Immunol 151:7095-7104;1993.
22. β6 T cell receptors in the cell-mediated immune response to Myeobacterium leprae. J Immunol 151:7105-7116;1993.